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Transcription repressionK-RBP is a KRAB-containing zinc ﬁnger protein with multiple zinc ﬁnger motifs and represses Kaposi's
sarcoma-associated herpesvirus (KSHV) transactivator RTA-mediated transactivation of several viral lytic
gene promoters, including the ORF57 promoter. Whether K-RBP binds DNA through its zinc ﬁngers and the
role of zinc ﬁnger domain in repressing gene expression are unclear. Here we report that K-RBP binds DNA
through its zinc ﬁnger domain and the target DNA sequences contain high GC content. Furthermore, K-RBP
binds to KSHV ORF57 promoter, which contains a GC-rich motif. K-RBP suppresses the basal ORF57 promoter
activity as well as RTA-mediated activation. The zinc ﬁnger domain of K-RBP is sufﬁcient for the suppression
of ORF57 promoter activation mediated by the viral transactivator RTA. Finally, we show that K-RBP inhibits
RTA binding to ORF57 promoter. These ﬁndings suggest that the DNA-binding activity of K-RBP plays an
important role in repressing viral promoter activity.© 2009 Elsevier Inc. All rights reserved.IntroductionKSHV is the etiologic agent of Kaposi's sarcoma (KS) (Chang et al.,
1994; Chang and Moore, 1996). Like other herpesviruses, KSHV
establishes a latent infection in infected cells but lytic replication can
occur spontaneously or upon activation by various stimuli (Jenner et
al., 2001; Sarid et al., 1998). Induction of KSHV lytic gene expression
occurs via the expression of the replication and transcription activator
RTA (Gradoville et al., 2000; Lukac et al., 1998; Sun et al., 1998). RTA
activates the transcription of various viral genes, and one of the highly
responsive genes to RTA-mediated transactivation is ORF57 (West and
Wood, 2003). The transactivation activity of RTA can be modulated by
many cellular and viral factors through different mechanisms (West
and Wood, 2003). One of these cellular factors is a KRAB-containing
zinc ﬁnger protein ZnF426 which we have identiﬁed previously; it
interacts with the KSHV RTA, and was named KSHV RTA binding
protein (K-RBP) (Wang et al., 2001).
KRAB (Kruppel-associated box)-containing zinc ﬁnger proteins are
the largest family of zinc ﬁnger regulatory proteins encoded in the
human genome with about 300 members. They play important roles
in various cellular processes, such as cell differentiation, apoptosis and
neoplastic transformation (Urrutia, 2003). The KRAB-containing zinc
ﬁnger proteins are characterized by the presence of 1–2 KRAB
domains at N-terminus followed by multiple C2H2 zinc ﬁnger motifs.
Many of the KRAB domains repress transcription when tethered toogy and School of Biological
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ll rights reserved.DNA. The KRAB domains also interact with proteins, such as TIF1β, and
their interactions are important for their repression function
(Moosmann et al., 1996). The tandem C2H2 zinc ﬁngers in KRAB-
containing zinc ﬁnger proteins were proposed to recognize speciﬁc
DNA elements and bind to DNA. However, not all zinc ﬁngers bind
DNA and not all zinc ﬁngers contribute equally to the DNA-binding
speciﬁcity in proteins containing multiple zinc ﬁnger motifs (Peng
et al., 2002). Furthermore, there is at least one zinc ﬁnger protein that
was found not to bind to DNA (Kwan et al., 2003).
Similar to other KRAB-containing zinc ﬁnger proteins, K-RBP
contains a Kruppel-associated box (KRAB) at the N-terminus and
multiple zinc ﬁnger motifs at the C-terminus; and it is expressed in a
number of different cell lines tested (Wang et al., 2001). The K-RBP
protein represses RTA-mediated transactivation and knockdown of K-
RBP expression enhances RTA-mediated transactivation of gene
driven by the ORF57 promoter. More interestingly, knockdown of K-
RBP expression in KSHV latently infected cells also increases KSHV-
RTA-mediated lytic gene expression, suggesting that K-RBP plays a
role in repressing RTA-mediated KSHV lytic gene expression in
latently infected cells (Yang and Wood, 2007). Therefore, it is of
interest to characterize the molecular properties of K-RBP to study the
mechanism of its function on viral promoters. The KRAB domain of K-
RBP is a repression domain but the role of its zinc ﬁnger motifs has not
yet been deﬁned (Yang and Wood, 2007). Whether the zinc ﬁnger
motifs of K-RBP bind to DNA, especially the viral promoter, and play a
role in repressing KSHV promoter is of interest and needs to be
investigated.
In this report, we demonstrate that K-RBP binds DNA through its
zinc ﬁnger motifs and the binding elements are GC-rich. In addition,
we found that the DNA-binding activity of K-RBP signiﬁcantly
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absence and presence of RTA. It is possible that K-RBP regulates other
viral gene expression and viral replication using a similar mechanism.
The characterization of K-RBP DNA-binding activity and identiﬁcation
of K-RBP binding sequences will provide important molecular insights
towards understanding the functions of K-RBP and its role in
regulating KSHV gene expression and replication at the molecular
level.
Results
Expression and puriﬁcation of recombinant K-RBP protein
K-RBP contains 12 zinc ﬁnger motifs, with 11 of them being classic
C2H2motifs and the other one being a non-typical C2H2motif (Fig.1A).
In addition, 6 of the 11 linkers between the zinc ﬁngers of K-RBP are
composed of the sequence TG(E)EKPY which is a common canonical
sequence in tandem DNA-binding C2H2 zinc ﬁnger proteins (Wolfe
et al., 2000). Even though zinc ﬁnger motifs are well-known DNA-Fig. 1. (A) Schematic representation of K-RBP protein showing the KRAB domain and 12
zinc ﬁnger motifs. Amino acid alignment of the zinc ﬁnger motifs in K-RBP showing the
amino acids involved in Zn2+ binding (in bold). The−1, +3 and+6 indicate the amino
acids in the α-helical region of a zinc ﬁnger motif that determine its DNA-binding
speciﬁcity. (B) Coomassie blue staining of cell lysates from E. coli expressing K-RBP
protein. Lane 1: protein marker; Lane 2: lysate from E. coli cells containing K-RBP
expression plasmid without IPTG induction; Lane 3: soluble fraction of Lysate from
E. coli cells containing K-RBP expression plasmid with IPTG induction; Lane 4: insoluble
fraction of the lysate from E. coli cells harboring K-RBP expression plasmid with IPTG
induction. Arrow indicates K-RBP protein. (C) Coomassie blue staining andWestern blot
analysis of His-tagged K-RBP protein after puriﬁcation, urea-solubilization and
refolding. Lane 1: Coomassie blue staining of K-RBP protein after puriﬁcation; Lane 2:
Coomassie blue staining of K-RBP protein after refolding; Lane 3: Western blot analysis
of protein using anti-His antibody after refolding. Arrow indicates K-RBP protein.
Fig. 2. DNA-binding activity of K-RBP protein. (A) The bacterially expressed K-RBP was
refolded and incubated with cellulose without DNA-conjugation or dsDNA cellulose.
The bound (B) and non-bound (NB) fractions were separated by centrifugation. The
bound protein was washed and eluted by increasing concentrations of NaCl in the
binding buffer. The K-RBP protein in different fractions was separated by SDS-PAGE and
analyzed by Western blot using anti-K-RBP antibody. (B) K-RBP was incubated with
dsDNA cellulose in the presence of ZnSO4 and EDTA. DNA cellulose bound protein was
eluted with 1.25% SDS. (C) Zinc ﬁnger domain, but not KRAB domain of K-RBP binds
DNA. The E. coli expressed His-tagged KRAB domain (1–98), zinc ﬁnger domain (141–
554), full-length K-RBP and E. coli lysate were resolved on SDS-PAGE, transferred to
PVDFmembrane and analyzed byWestern blot using anti-His antibody (left panel). The
second membrane with the same samples was incubated in K-RBP refolding buffer
overnight at 4 °C and hybridized to the random dsDNA probe labeled with [α-32P] dATP
(right panel).binding motifs, not all zinc ﬁnger proteins bind DNA (Kwan et al.,
2003). To test whether K-RBP binds to DNA, recombinant His-tagged
K-RBP was over-expressed to a high level in E. coli and could be
detected in the insoluble fraction of the bacterial lysate (Fig. 1B). The
protein was puriﬁed and then refolded by dialyzing against refolding
buffer. Coomassie blue staining of the SDS-PAGE and Western blot
analysis showed that the refolded protein was pure (Fig. 1C). The
puriﬁed and refolded K-RBP protein was subsequently used for DNA-
binding analysis.
K-RBP binds DNA via its zinc ﬁnger domain
To investigate whether K-RBP binds DNA, we conducted an in vitro
DNA cellulose assay. K-RBP protein was examined for its association
with cellulose alone or cellulose conjugated to dsDNA. Consistent with
it being a potential DNA-binding protein, K-RBP bound tightly to
dsDNA cellulose but not to cellulose alone (Fig. 2A). In addition, the
DNA-binding activity of K-RBP was affected by the addition of Zn2+.
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bound to DNA, and the addition of metal-chelating reagent EDTA
inhibited K-RBP binding (Fig. 2B). This suggests that Zn2+ is required
for optimal DNA binding by K-RBP. Similar effect was also observed
with another KRAB-containing zinc ﬁnger protein (Jheon et al., 2001).
To examine whether K-RBP binds DNA through its zinc ﬁnger
domain, full-length His-tagged K-RBP and two truncated K-RBP
clones, KRAB domain K-RBP1-98 and zinc ﬁnger domain K-RBP141-
554, were constructed, and the resulting proteins expressed in E. coli
were used in DNA ﬁlter binding assay. Membrane-immobilized full-
length K-RBP and zinc ﬁnger domain (K-RBP141-554), but not KRAB
domain (K-RBP1-98), were found to bind [α-32P] dATP labeled DNA
(Fig. 2C). These results indicate that the zinc ﬁnger domain of K-RBP is
responsible for the DNA-binding activity of K-RBP.
Identiﬁcation of K-RBP binding sequences
To investigate whether K-RBP binds speciﬁc DNA sequences, we
incubated the His-tagged K-RBP fusion protein with a pool of double-
stranded 63-mers containing 27 nucleotides of random sequence,
N27. The K-RBP bound oligonucleotides were recovered by Ni-NTA,
ampliﬁed by PCR, and reselected as described in Materials and
methods and shown in Fig. 3A. A total of 33 clones were analyzed and
70% of them (23 clones) contain (T/G)CGG or its complementary
sequence CCG(A/C) in the randomly synthesized region (data not
shown). This result suggests that (T/G)CGG sequence could be a core
motif for K-RBP binding.
To better deﬁne the K-RBP binding sequences, we performed a
second set of selectionwith oligomers containing the central CGG core
identiﬁed during the ﬁrst selection ﬂanked by 14 and 15 nucleotides of
random sequences at each end (N14-CGG-N15). After 8 rounds of
selection, the selected oligonucleotides were cloned and sequenced. A
total of 100 clones were sequenced, of which 82 good quality
sequences were analyzed and the frequencies of different nucleotides
appearing at each position were calculated. The analysis revealed a
GC-rich feature, with a GC-rich element in the consensus sequence: G
(G/T)GGG(G/T)G(G/T)NNGCGGG(G/T)GG (Fig. 3B). Notably, several
sequences featured multiple times among the selected 82 clones, and
all of them were rich in GC content. These results suggest that K-RBP
preferably binds to sequences with high GC content.
To conﬁrm the binding of K-RBP with the selected sequences, we
performed EMSA using one of the selected DNA target clone #14 as a
probe. This sequence was present in 7 out of 82 analyzed sequences
(Fig. 3C). The result showed that the K-RBP protein bound the probe
speciﬁcally, and increasing amounts of protein resulted in stronger
binding (Fig. 3C, lanes 2 and 3). The binding was competed efﬁciently
by the unlabeled clone #14 probe but not by Oct-1 binding element
probe which is not GC-rich (Fig. 3C, lanes 4 and 5). In addition, when
the K-RBP protein was depleted by Ni-NTA beads prior to binding, the
intensity of the protein–DNA complex decreased. However, the
addition of GST beads had no effect (Fig. 3C, lanes 6 to 8). We also
used anti-His antibody to test for a supershift of the K-RBP/DNA
complex. However, the addition of this antibody did not generate a
supershifted band but the intensity of the K-RBP/DNA complex band
decreased signiﬁcantly. In contrast, the anti-Flag antibody had little
effect (Fig. 3C, lanes 9 to 12). These results suggest that binding of K-
RBP to this probe is speciﬁc.
K-RBP binds KSHV ORF57 promoter and suppresses its activity
K-RBP has been shown to suppress KSHV ORF57 and K8 promoter
activities activated by RTA (Yang and Wood, 2007). We found a GC-
rich element beside RTA response elements in ORF57 promoter. The
ORF57 gene is an important early protein required for KSHV lytic
replication (Duan et al., 2001; Lukac et al., 2001; Wang et al., 2005)
and we tested whether K-RBP actually binds this promoter andwhether the binding can lead to the suppression of the promoter
activity. Fig. 4A shows the schematic representation of the ORF57
promoter in which we have identiﬁed at least two RTA binding
elements (RRE1 and RRE2) (Wang et al., 2005). The GC-rich element is
located between RRE1 and RRE2.We then performed EMSA using 57R,
57RRE2, the entire promoter element 57P and clone #14 as probes to
determine their interaction with K-RBP. K-RBP bound to the 57P and
57R probes, but poorly to 57RRE2. Binding of K-RBP to 57P was
stronger than that of 57R (Fig. 4B). These results suggest that even
though the AT-rich 57RRE2 is not a preferable binding target of K-RBP,
it enhances the binding of K-RBP to 57R since stronger binding of K-
RBP to 57P was observed relative to 57R (Fig. 4B). The binding of K-
RBP to 57R was speciﬁc because increasing protein/DNA complex was
observed with an increasing amount of protein added (Fig. 4C, lanes 7
and 8). The addition of the various unlabeled competitors which
included clone #14, 57R and 57P signiﬁcantly decreased binding of K-
RBP to 57R, but the addition of 57RRE2 and the unrelated Oct-1
binding element had little or no inhibitory effect (Fig. 4C, lanes 3, 4, 5,
9 and 10). It is interesting to note that although clone #14 cold probe
can only partially compete with K-RBP for binding to 57R at an 80-fold
excess, it completely inhibited K-RBP binding at a 200-fold excess
(data not shown). This suggests that the binding between K-RBP and
ORF57 promoter is strong. Depletion of K-RBP protein by Ni-NTA
beads but not GST beads reduced the intensity of the protein–DNA
complex (Fig. 4C, lanes 11 to 13). Also, anti-His antibody diminished K-
RBP binding to 57R, but anti-Flag antibody had no effect (Fig. 4C, lanes
14 to 15). These results demonstrate that K-RBP can speciﬁcally bind
to ORF57 promoter.
Since K-RBP is a transcriptional repressor, the binding of K-RBP to
the ORF57 promoter may play a role in suppression of the promoter
activity. Therefore we performed luciferase reporter assay in trans-
fected 293T cells to investigate this possibility. The schematic
representations of the luciferase reporter constructs of ORF57
promoter and the mutants used in the study are shown in Fig. 5A.
Plasmid pGL3-basic was used for the construction of the luciferase
reporters. The p57Pluc1 and p57-3RRE contain the intact ORF57 RREs;
the p57-3RRE4 has deletion in RRE1 and does not contain the GC-rich
element; p57-3RRE2 has a deletion in the GC-rich element of p57-
3RRE. K-RBP had only a marginal suppressive effect on pGL3-basic at
high concentration (Fig. 5B), but strongly suppressed p57Pluc1 and
p57-3RRE with the intact GC-rich element (Figs. 5C and D). As
expected, K-RBP did not suppress p57-3RRE4 and p57-3RRE2, which
lack the GC-rich element (Figs. 5E and F). These results together
suggest that K-RBP binds the ORF57 promoter via the GC-rich element
and functionally suppresses the promoter activity.
The zinc ﬁnger domain of K-RBP alone can repress KSHV RTA-activated
ORF57 gene promoter
We have shown that K-RBP can repress RTA-mediated ORF57 gene
promoter activation in 293T cells in an earlier study (Yang and Wood,
2007). Similar effect can be observed in another cell line, BJAB cells,
and the expression of K-RBP readily suppressed RTA-activated ORF57
gene expression (Fig. 6A). We next sought to determine whether the
DNA-binding activity of K-RBP is required to mediate the repression.
Several GAL4BD-tagged K-RBP deletion mutants were tested for their
effect on RTA-activated ORF57 promoter. The use of GAL4BD tag would
provide nuclear localization to the truncated proteins and the ORF57
promoter construct does not contain GAL4 binding site. Plasmids
pBDK-RBP42-98 and pBDK-RBP1-98 retain the N-terminal KRAB
domain; pBDK-RBP99-554 and pBDK-RBP214-554 retain the full and
partial zinc ﬁnger domains, respectively (Fig. 6E). Interestingly, as
shown in Figs. 6B and C, K-RBP99-554 repressed RTA-activated ORF57
luciferase reporter activity to a similar level as full-length K-RBP, but
K-RBP1-98 failed to cause any repression. On the contrary, the
addition of deletion mutant K-RBP1-98 enhanced RTA-mediated
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Fig. 4. K-RBP binds ORF57 promoter. (A) Schematic representation of RRE in KSHV ORF57 promoter on which the locations of various putative promoter-regulatory elements are
indicated. The whole 57RRE regionwas boxed. The GC-rich region is in gray letters. The RBP-Jk binding element is underlined. The bold lines below the sequence indicate the ORF57
promoter probes that were used for EMSA. (B) EMSA of the clone #14, 57R, 57RRE2 and 57P probes with K-RBP protein. Puriﬁed His-tagged K-RBP was incubated with 32P labeled
probes. Arrow indicates the weak binding between K-RBP and 57RRE2. (C) K-RBP binds 57R probe in EMSA. Experiment was performed as described in Fig. 3C except that different
unlabeled competitors were used as indicated. Arrow indicates the binding complex between K-RBP and 57R. One μl K-RBP protein contains about 5 ng puriﬁed K-RBP protein.
225Z. Yang et al. / Virology 391 (2009) 221–231transcriptional activation by about 2-fold (Fig. 6C). The effect of
deletion mutant K-RBP214-554 was similar to K-RBP99-554 which
also repressed RTA-mediated transactivation (Fig. 6E). The effect ofFig. 3. Selection of K-RBP binding sequences. (A) Schematic representation of the procedur
binding. Numbers indicate the frequencies of the speciﬁc nucleotide at each position (Pos).
sequence shown in the bottom. The underlined CGG motif was pre-synthesized in the pool o
probewas labeled with [α-32P]dATP. The clone #14 and Oct-1 probewere used as unlabeled c
labeled probe. Various amounts of Ni-NTA agarose beads (5 and 15 μl) were used to remove t
anti-His or Flag antibodies were added in the reaction prior to adding the probe as shown in
contains 5 ng puriﬁed K-RBP protein approximately.deletion mutant K-RBP42-98 was similar to K-RBP1-98. It enhanced
RTA-mediated transactivation by about 2-fold (Fig. 6E and data not
shown). The repression of RTA-mediated transactivation by the K-RBPe used to identify K-RBP binding sequences. (B) Consensus (Con) sequences for K-RBP
The most abundant nucleotides at each position were used to generate the consensus
f the second round selection oligomers. (C) K-RBP binds clone #14 probe in EMSA. The
ompetitors. Unlabeled competitors were added at an 80–100-fold molar excess over the
he His-tagged K-RBP protein in EMSA. GST beads (15 ml) were used as a control. Mouse
lanes 11 and 12. The arrow indicates the bound complex. One microliter K-RBP protein
Fig. 5. K-RBP suppresses KSHV ORF57 promoter is dependent on the GC-rich element. (A) Schematic representation of the luciferase promoter reporters used. (B–F) 293T cells were
transfected with 100 ng of pGL3-basic as shown in (B), p57Pluc1 in (C), p57-3RRE in (D), p57-3RRE4 in (E), p57-3RRE2 in (F) using the indicated amounts of K-RBP plasmid pcDNAK-
RBP. The luciferase activities were detected at 24 h post-transfection. For all transfections, total DNA amounts used in each transfection were normalized by the addition of control
plasmid. The percentages of inhibition by K-RBP were indicated. The error bars indicate standard deviations of at least 3 independent experiments. Transfection efﬁciency for each
experiment was normalized using a β-Gal expression plasmid as internal control. The basal levels of the promoter activity were normalized to 100%.
226 Z. Yang et al. / Virology 391 (2009) 221–231zinc ﬁnger domain was also observed in 293T cells (Data not shown).
Since K-RBP99-554 retained its repressor activity on RTA-mediated
activation of ORF57 promoter but K-RBP1-98 did not, we examined
the expression levels of the twomutants in comparison to the intact K-
RBP (Fig. 6D). K-RBP1-98 was expressed at relatively higher level,
while the BDK-RBP99-554 was expressed at lower level, suggesting
that the inability of K-RBP1-98 to cause repression was not due to
inefﬁcient expression of the K-RBP1-98 protein. Together our results
suggest that the DNA-binding zinc ﬁnger domain of K-RBP plays an
important role in repressing RTA-mediated transactivation of the
ORF57 promoter.
Inhibition of RTA binding to ORF57 promoter by K-RBP
The zinc ﬁnger domain of K-RBP is sufﬁcient to repress RTA-
mediated ORF57 promoter transactivation and this domain mediatesDNA-binding activity, which suggests that K-RBP may inhibit RTA
binding to ORF57 promoter to repress RTA-mediated transactivation.
We ﬁrst showed that the zinc ﬁnger domain of K-RBP was sufﬁcient to
bind to ORF57 promoter. As shown in Fig. 7A, the membrane-
immobilized zinc ﬁnger domain of K-RBP was tightly bound to [α-32P]
dATP labeled 57P probe as well as to the full-length K-RBP. This is
consistent with the result showing that the zinc ﬁnger domain was
responsible for the DNA-binding activity of K-RBP (Fig. 2C). Since RTA
also binds to ORF57 promoter (Lukac et al., 2001), we then examined
RTA binding to the promoter in the presence of K-RBP protein using
EMSA. The baculovirus expressed RTA bound to 57P probe efﬁciently
and the binding of RTA to 57P was competed efﬁciently by unlabeled
57P probe, but not by an Oct-1 binding element (Fig. 7B, lanes 3 and
4). In order to determine whether K-RBP affects RTA binding to 57P,
EMSAwas carried out in the presence of both RTA and K-RBP proteins.
As shown in Fig. 7B (lanes 6–8), RTA binding to 57P was decreased
Fig. 6. Effect of RTA-mediated transactivation of ORF57 promoter (p57Pluc1) by K-RBP and its mutants in BJAB cells. (A–C) BJAB cells were transfected with 1 μg of p57Pluc1,
expression plasmids of RTA and GAL4BD-tagged K-RBP in (A), K-RBP99-554 (zinc ﬁngers) in (B), K-RBP1-98 (KRAB) in (C). The luciferase activities were detected at 48 h post-
transfection. In all transfections, the total DNA amounts used in each transfection were normalized by the addition of control expression plasmid. The basic promoter activity was
normalized as 1 fold. The error bars indicate standard deviations of at least 3 independent experiments. Transfection efﬁciency for each experiment was normalized using a β-Gal
expression plasmid as internal control. (D) The expression of K-RBP and its mutants. The indicated proteins expressed from plasmids were immunoblotted with rabbit anti-GAL4BD
antibody. The higher molecular band from the control plasmid in the ﬁrst lane is probably a GAL4BD fusion protein translated from a read-through transcript from the vector. Tubulin
was used as the loading control. (E) Schematic diagrams of K-RBP deletion mutants used and their effects on RTA-mediated ORF57 transactivation. “+” and “−” indicate the ability of
the various deletion clones to repress RTA-mediated transactivation.
227Z. Yang et al. / Virology 391 (2009) 221–231signiﬁcantly as an increasing amount of K-RBP was added. The upper
RTA/57P complex disappeared and the intensities of the middle and
lower RTA/57P complexes decreased. Our results suggest that K-RBP
can inhibit the binding of RTA to ORF57 promoter. The inhibition of
RTA binding to ORF57 promoter by K-RBP likely contributes to the
repression of RTA-mediated ORF57 promoter transactivation.
Discussion
In this study, we characterized the DNA-binding activity of K-RBP
and demonstrated that the DNA-binding zinc ﬁnger domain of K-RBP
plays an important role in suppressing RTA-mediated ORF57 promoter
transactivation. This study, as well as the earlier ﬁndings that KSHVRTA utilizes other cellular factors such as IRF-7 and RBP-Jκ to regulate
the transactivation activity (Liang et al., 2002; Wang et al., 2005),
supports that the modulation of RTA–DNA binding is an important
mechanism to regulate RTA activity.
DNA-binding activity of K-RBP
Even though KRAB-containing zinc ﬁnger proteins are predicted to
function as sequence-speciﬁc transcriptional repressors by binding
DNA via the zinc ﬁngers and repressing transcription using the KRAB
domain (Gebelein and Urrutia, 2001; Urrutia, 2003), recent studies
have shown that zinc ﬁngers are more diverse in selecting their
binding partners than previously thought. The zinc ﬁngers could be
Fig. 7. Inhibition of RTA binding to ORF57 promoter by K-RBP. (A) The zinc ﬁnger
domain of K-RBP binds ORF57 promoter. The E. coli expressed His-tagged zinc ﬁnger
domain, full-length K-RBP and E. coli lysate were resolved on SDS-PAGE, transferred to
PVDF membrane and analyzed by Coomassie blue staining (left panel). The second
membrane with the same samples was refolded and hybridized to the 57P probe
labeled with [α-32P] dATP (right panel). (B) Baculovirus expressed RTA, E. coli
expressed K-RBP and [α-32P] dATP labeled 57P probewere used in EMSA. The EMSAwas
performed as described in Fig. 3C except that different unlabeled competitors and
proteins were used as indicated in the ﬁgure. Open arrows indicate speciﬁc binding of
RTA to probes. Filled arrows indicate the binding of K-RBP to probes. Numbers below the
bands indicate the relative intensities of the bands measured by Image J.
228 Z. Yang et al. / Virology 391 (2009) 221–231RNA or protein binding motifs (Brayer and Segal, 2008), and not all
zinc ﬁnger proteins were shown to bind to DNA (Kwan et al., 2003).
While some studies have suggested that the −1, +3 and +6 amino
acids (Fig. 1A) in the α-helical region of a zinc ﬁnger motif determine
its DNA-binding speciﬁcity (Pavletich and Pabo, 1991, 1993; Wolfe
et al., 2000), other studies have reported that other amino acids in the
α-helix also contribute to the binding speciﬁcity of a zinc ﬁnger motif
(Peng et al., 2002). In addition, in the context of a full-length protein,not all zinc ﬁnger motifs bind DNA (Peng et al., 2002; Zheng et al.,
2000).
Since K-RBP binds DNA through its zinc ﬁngers, in order to study
whether K-RBP regulates RTA-mediated transactivation via DNA
binding, we decided to examine the DNA-binding activity of K-RBP.
We chose the random selection approach to identify K-RBP binding
DNA sequences because the accurate prediction of zinc ﬁnger protein
binding sites is unreliable. Among the target sequences that were
bound by K-RBP, the majority of them contain GC-rich elements
throughout the sequences. This is consistent with the ﬁndings that the
consensus binding sequences of many zinc ﬁnger proteins are also GC-
rich even though there are a few that are not (Christy and Nathans,
1989; Swirnoff and Milbrandt, 1995). Our results suggest that K-RBP
preferentially binds to the consensus sequence but its targets may not
be limited to these sequences. The relatively broad binding speciﬁcity
of K-RBP was also evidenced by its tight binding to ORF57 promoter,
which does not show 100% similarity to the selected consensus
sequence. The plasticity of K-RBP DNA binding is not unprecedented
since this reﬂects the complexity of DNA binding for a protein with
multiple zinc ﬁngers. This has also been observed in other zinc ﬁnger
proteins. For example, the cellular protein Ying Yang 1 (YY1) can bind
to several different consensus sequences (Hyde-DeRuyscher et al.,
1995; Kim and Kim, 2008). Further studies such as mutagenesis
analysiswill be needed to dissect the preferential binding sites and the
ﬁngers within K-RBP responsible for DNA and protein bindings.
The repression of KSHV ORF57 promoter activity by K-RBP
KSHV establishes latency after primary infection, which is
characterized by the repression of a number of viral lytic genes.
There are multiple mechanisms involved in suppression of KSHV lytic
gene expression but they are not fully understood. A number of
cellular factors may contribute to the maintenance of KSHV latency,
and K-RBP is one of them (Brown et al., 2003; Gwack et al., 2001, 2003;
Wang et al., 2005). K-RBP negatively regulates RTA-activation of lytic
genes such as ORF57 gene (Yang and Wood, 2007). Our results here
indicate that one of the mechanisms for repression of ORF57
expression is the direct binding of K-RBP to its promoter. The binding
of K-RBP to viral ORF57 promoter may bring co-repressors to silence
gene expression. An example is TIF1β which was found to interact
with the KRAB domain of K-RBP and some other KRAB-containing
proteins (Abrink et al., 2001; Yang and Wood, 2007). The repression
mechanism of KRAB-containing zinc ﬁnger proteins has been shown
to involve recruitment of repression complex by KRAB domain,
including TIF1β (transcription intermediary factor 1β) (Friedman
et al., 1996; Kim et al., 1996; Moosmann et al., 1996). The KRAB/TIF1β
complex recruits cellular factors heterochromatin protein 1 (HP1)
family, a family of non-histone heterochromatin-associated proteins
with gene-silencing function, HDAC and SETDB1, a SET domain-
containing protein that methylates lysine 9 of histone H3 to the DNA
regulatory region (Cammas et al., 2004; Lechner et al., 2000; Nielsen
et al., 1999; Peng et al., 2000; Ryan et al., 1999; Schultz et al., 2002,
2001; Sripathy et al., 2006). This may also explain why the KRAB
domain of K-RBP in the absence of the zinc ﬁnger motifs can
moderately enhance RTA-mediated transactivation (Fig. 6C). It may
function as a dominant-negativemutant that interacts with repressors
to prevent their targeting to ORF57 promoter to mediate repression.
Our study showed that the zinc ﬁnger domain of K-RBP alone can
bind to ORF57 promoter, compete with RTA in binding to ORF57
promoter and repress RTA-activated ORF57 promoter. This suggests
that the DNA-binding activity of K-RBP plays an important role for
inhibiting RTA-mediated transactivation. However, the DNA-binding
activity of K-RBP may be not the sole mechanism in repressing RTA-
mediated transactivation. An example is the KSHV ORFK8, it contains
the GGGGGTGG sequence motif and its activation by RTA can be
repressed by K-RBP (Yang and Wood, 2007). However, K-RBP cannot
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lished data). This suggests that the interaction between K-RBP and
RTA may also play a role in the repression of RTA-mediated
transactivation, in addition to the DNA-binding activity of K-RBP. It
is also possible that a combination of the above mechanisms could be
involved in the repression of RTA-mediated transactivation by K-RBP.
The potential role of K-RBP in KSHV life cycle
We have recently found that RTA could induce K-RBP degradation
through a proteasome-dependent pathway leading to lytic reactiva-
tion (Yang et al., 2008). It is likely that there is a dynamic relationship
between repression by K-RBP and K-RBP degradation induced by RTA
in KSHV infected cells, and this balance may change at various stages
of KSHV infection. During latency, RTA-mediated transactivation may
be blocked by K-RBP and other repressors when RTA expression level
is very low. However, during lytic induction, when RTA expression is
induced, RTA may overcome the suppression and lead to lytic
replication.
The identiﬁcation of K-RBP as a repressor of KSHV gene expression
and as an ORF57 promoter binding protein is interesting because other
KRAB-containing zinc ﬁnger proteins have also been found to be
involved in regulating viral replication. K-RBP is one of a fewmembers
of the zinc ﬁnger protein family that are known to repress viral
replication. The KRAB-containing zinc ﬁnger protein OTK18 represses
human immunodeﬁciency virus type 1 (HIV-1) replication (Carlson
et al., 2004). Recently, a KRAB-containing proteinwas found to repress
lentivirus proviral transcription (Bulliard et al., 2006). Engineered
KRAB-containing zinc ﬁnger proteins were also used to repress HIV
transcription and replication in several studies (Eberhardy et al., 2006;
Reynolds et al., 2003; Segal et al., 2004). The DNA-binding activity
plays an important role in specifying its effective targets. It is possible
that the KRAB-containing zinc ﬁnger proteins play a broader role and
function as intracellular antiviral molecules to inhibit viral replication.
This possibility needs to be further explored.
K-RBP may have other roles in KSHV life cycle in addition to
transcriptional regulation. The origin of replication of KSHV is a GC-
rich region, whether K-RBP binds this region to regulate viral
replication needs to be investigated (Russo et al., 1996). K-RBP may
also regulate the expression of other KSHV genes or other viruses such
as Epstein–Barr virus (EBV), since co-infection of primary effusion
lymphoma by both KSHV and EBV occurs frequently (Drexler et al.,
1998), and there are a number of KSHV and EBV viral promoters
harboring GC-rich elements. Further study will be needed to map
other K-RBP binding promoters on KSHV viral genome. This may
include investigating the in vivo binding targets of K-RBP on viral and
cellular genome by Chromatin immunoprecipitation followed by new
deep pyrosequencing technique. In conclusion, the regulation of KSHV
gene expression by K-RBP through its DNA-binding activity suggests a




Expression plasmids pcDNAK-RBP and pcDNAORF50, which
encode full-length K-RBP and KSHV RTA, have been described
elsewhere (Wang et al., 2001). The mammalian expression plasmids
GAL4 DNA-binding domain (GAL4BD)-tagged K-RBP and its mutant
clones pBDK-RBP, pBDK-RBP42-98, pBDK-RBP1-98, pBDK-RBP214-554
and pBDK-RBP99-554 encoding full-length, K-RBP fragments from
amino acids 42 to 98, 1 to 98, 214 to 554 and 99 to 554 respectively,
have also been described elsewhere (Yang and Wood, 2007). The
E. coli expressionplasmids pET28K-RBP, pET28K-RBP1-98 and pET28K-
RBP141-554 were constructed by PCR ampliﬁcation of correspondingK-RBP DNA fragments and inserting into pET28 vector. Reporter
plasmid p57Pluc1, containing promoter region of KSHVORF57, has also
been described previously (Duan et al., 2001). The luciferase reporter
plasmids p57-3RRE, p57-3RRE2 and p57-3RRE4, as shown in Fig. 5,
were constructed by amplifying corresponding DNA fragments of
ORF57 promoter by PCR and inserting into pGL3-basic vector
(Promega, Madison, WI). The β-galactosidase (β-Gal) expression
plasmid pCMV-β was purchased from BD Clontech (Mountain View,
CA) and used for the normalization of transfection efﬁciency. All
inserts ampliﬁed by PCR were conﬁrmed by DNA sequence analysis.
Expression, puriﬁcation and refolding of recombinant K-RBP protein
E. coli DE3 cells containing His-tagged K-RBP expression plasmid
pET28K-RBP were induced by 1 mM isopropyl-beta-D-thiogalactopyr-
anoside (IPTG) at 37 °C for 4–5 h to express K-RBP protein. The cells
were suspended in 1× PBS containing 1 mM Phenylmethylsulphonyl-
ﬂuoride (PMSF) and then lysed by sonication. The insoluble fraction
was collected by centrifugation and washed sequentially with 1× PBS
containing 2 M urea, 0.1% SDS, 1% NP-40 and 1% TritonX-100. The
majority of the insoluble fraction after extensive washing contains K-
RBP protein (see Fig. 1B). The puriﬁed protein was solubilized in 1×
PBS containing 8 M Urea, and was renatured by successive dialysis
against refolding buffer (25 mM HEPES, pH 7.9, 50 mM NaCl, 0.1% NP-
40, 1 mM PMSF, 0.16 mM dithiothreitol [DTT], 10 μM ZnSO4, 10%
glycerol) containing 4, 2, 1 and 0 M Urea at 4 °C. The resulting protein
was evaluated by coomassie blue staining and Western blot analysis
with anti-His antibody following SDS-PAGE. The protein expression of
K-RBP1-98 and K-RBP141-554 was carried out in E. coli similar to K-
RBP protein.
Expression and puriﬁcation of recombinant KSHV RTA protein
KSHV RTAwas expressed in Sf9 cells using Bac-N-Blue baculovirus
expression system (Invitrogen, Carlsbad, CA). Brieﬂy, full-length KSHV
RTA was PCR-ampliﬁed and cloned into pBlueBacHis2A vector, which
was co-transfected into Sf9 cells with the wild-type baculovirus
vector. Recombinant virus was plaque puriﬁed twice to obtain a high
titer stock. To express protein, Sf9 cells were infected at an MOI of 10
with the recombinant virus. The puriﬁcation of His-tagged RTA
proteinwas carried out using Ni-NTA superﬂow (Qiagen, Valencia, CA)
according to the manufacturer's recommendation.
DNA cellulose binding assay
DNA cellulose binding assay was carried out according to
published procedure with modiﬁcations (Nishiya et al., 1998). Brieﬂy,
approximately 5 μg of K-RBP protein was incubated with 5 mg of
cellulose or double-stranded (ds) DNA cellulose in binding buffer
(25 mM HEPES, pH 7.9, 50 mM KCl, 0.1% NP-40, 1 mM PMSF, 0.16 mM
DTT,10 μMZnSO4,10% glycerol) in 0.5ml volume overnight at 4 °C. The
cellulose was preincubated with 5% bovine serum albumin (BSA) in
binding buffer for 1 h prior to use. After incubation with K-RBP, the
cellulose/protein complex was washed 4 times with binding buffer.
The protein bound to DNA cellulose was eluted with 1.25% SDS or
binding buffer containing increasing concentration of NaCl, resolved
by SDS-PAGE, and then detected byWestern blot analysis using rabbit
anti-K-RBP antibody.
DNA ﬁlter binding assay
Filter binding assay was adapted from published procedure with
some modiﬁcations (Jheon et al., 2001). Cell lysates from E. coli were
separated by SDS-PAGE and transferred to Polyvinylidene ﬂuoride
(PVDF) membrane. The membrane was renatured overnight at 4 °C in
binding buffer (25 mM HEPES, pH 7.9, 50 mM KCl, 0.1% NP-40, 1 mM
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testes DNA). DNA probes were end-labeled with [α-32P] dATP
(PerkinElmer Life Sciences, Waltham, MA) using Klenow DNA
polymerase (New England Biolabs, Ipswich, MA). Approximately
1×105 cpm/ml of the labeled DNA was hybridized to the membrane
in binding buffer overnight at room temperature. The membrane
was washed for 6 h (3–4 times) at room temperature in 50 mM
KCl, and the protein/DNA-binding complexes were analyzed by
autoradiography.
Selection of K-RBP binding sequences
The selection of consensus DNA-binding sequences of K-RBP was
carried out by the Selected and Ampliﬁed Binding Sequence (SAAB)
method with modiﬁcations (Blackwell and Weintraub, 1990). For the
ﬁrst set of binding sequence selection, a pool of double-stranded
random oligomers was obtained by PCR ampliﬁcation using the 63-
base random oligonucleotide N27 (5′-ATGGTACCGAAGTCCTCA-N27-
GACATCAGTCTCGAGTCT-3′) as template (125 ng), 0.5 μg of primer 1
(5′-ATGGTACCGAAGTCCTCA-3′) and 0.5 μg of primer 2 (5′-AGACTC-
GAGACTGATGTC-3′). The dsDNA (~0.5 μg) was incubated with 0.5 μg
of His-tagged K-RBP protein for 1 h with rotation in a ﬁnal volume of
150 μl of binding buffer (25mMHEPES, pH 7.9, 50mMKCl, 0.1% NP-40,
1 mM PMSF, 0.16 mM DTT, 10 μM ZnSO4, 10% glycerol) containing
10 μg/ml poly(dI·dC) at room temperature. The resulting K-RBP/DNA
complex was isolated by incubating the solution with Ni-NTA
superﬂow for 1 h, and the beads were washed 4 times by binding
buffer. The K-RBP/DNA complex was separated from Ni-NTA by 100 μl
of elution buffer (250mM imidazole, 300mMNaCl, 50 mMNaH2PO4),
heated at 95 °C for 10 min and partially puriﬁed by Qiagen nucleotide
removal kit. Ten μl of the recovered DNA was ampliﬁed by PCR with
primers 1 and 2. After seven rounds of selection and puriﬁcation, the
ﬁnal round PCR product was cloned directly into pGEM-T easy vector
system (Promega), ampliﬁed and sequenced.
The second set of binding sequence selectionwas performed using
a pool of double-stranded random oligomers obtained by PCR, using
100 ng of the 68-base random oligonucleotide N14-CGG-N15 (5′-
GACTGACAGATCTGTGAG-N14-CGG-N15-CTGTCATATGACAGTCAC-3′)
as template, 0.5 μg of primer 3 (5′-GACTGACAGATCTGTGAG-3′) and
0.5 μg of primer 4 (5′-GTGACTGTCATATGACAG-3′). Binding was
carried out as described above but the selection was carried out for
eight rounds. The PCR product from the eighth round was inserted
into pGEM-T and sequenced.
DNA sequencing and analysis
After multiple rounds of selection, PCR ampliﬁcation and puriﬁca-
tion, the afﬁnity-selected oligonucleotides were ligated into the
pGEM-T vector. After transforming into E. coli, the DNA inserts from
the resulting clones were sequenced. The sequences were analyzed,
aligned using the BioEdit sequence analysis program and adjusted
manually.
Electrophoretic mobility shift assay (EMSA)
The double-stranded oligonucleotides used for EMSA were end-
labeled with [α-32P] dATP using Klenow DNA polymerase. The labeled
probes were incubated with the protein for 30 min in binding buffer
(10 mM Tris-HCl [pH 7.5], 150 mM KCl, 5.7 mM MgCl2, 1 mM EDTA,
0.2 μg of poly[dI·dC], 5 μg of BSA, 0.67 mM DTT, 0.67 mM PMSF, 5%
glycerol) in the presence or absence of unlabeled probes. If antibody
was added to detect supershift, the antibody and protein were
preincubated for 20 min before the labeled probes were added. The
protein/DNA-binding samples were loaded onto a 4.5% polyacryla-
mide gel in 1xTGE buffer (5 mM Tris, 190 mM glycine, and 1mM EDTA
[pH 8.3]), then dried and exposed to X-ray ﬁlm. Signal intensities werequantiﬁed by the NIH Image J software. The probes 57P, 57R and
57RRE2 that were used are indicated in Fig. 4A. The probe clone #14
is indicated in Fig. 3D. One strand of Oct-1 binding sequence is:
5′-TGTCGAATGCAAATCACTAG-3′.
Antibodies
Anti-K-RBP antibody was described elsewhere (Yang and Wood,
2007). The mouse anti-tubulin monoclonal antibody was purchased
from Sigma (St. Louis, MO). The mouse anti-Flag M2 monoclonal
antibody was purchased from Stratagene (La Jolla, CA) and the mouse
anti-His monoclonal antibody was purchased from BD Clontech.
Mouse and rabbit anti-GAL4BD antibodies were purchased from Santa
Cruz Biotechnology (Santa Cruz, CA).
Cell culture, transfection, and luciferase assay
Human 293T cells were grown in Dulbecco's Modiﬁed Eagle
Medium (DMEM, Invitrogen) supplemented with 10% fetal bovine
serum (FBS, Invitrogen) and 1% penicillin-streptomycin (Mediatech,
Manassas, VA) at 37 °C with 5% CO2. Transfection of 293T cells was
carried out using Lipofectamine 2000 (Invitrogen) according to
manufacturer's recommendations. Human BJAB cells were grown in
RPMI 1640 medium (Gibco BRL) supplemented with 10% FBS and 1%
penicillin-streptomycin at 37 °Cwith 5% CO2. Transfection of BJAB cells
was conducted using Amaxa Nucleofactor according tomanufacturer's
recommendations. For all transfections, the total DNA amounts used
in each transfection were normalized by adding control plasmid.
Luciferase activities were determined at 48 h post-transfection by the
Luciferase Assay System (Promega) according to the manufacturer's
recommendations. Each result was an average of at least three
independent transfections. Transfection efﬁciency for each experi-
ment was normalized by co-transfecting with a β-gal expression
plasmid pCMV-β which was used as internal control.
Western blotting analysis
Proteins were separated by SDS-PAGE and transferred to PVDF
membrane. The membrane was blocked with 3–5% nonfat dry milk in
TBST (50 mM Tris [pH 7.5], 200 mM NaCl, 0.05% Tween 20) at room
temperature for 1 h. The membrane was then incubated with primary
antibody with the same concentration of milk in TBST for 1 h at room
temperature, washed three times with TBST for 15 min, then
incubated with the HRP-conjugated secondary antibody at room
temperature for 1 h. The membrane was again washed three times
with TBST, treated with SuperSignal (Pierce Biotechnology) detection
reagents and exposed to Kodak Light ﬁlm.
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